ACH Accendra Health, Inc. Common Stock
NYSE · Health Care · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Oca 24, 2024ACH Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
ACH Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
| Ex-tarihi | Bölünme | Tür |
|---|---|---|
| 01 Nisan 2010 | 3-for-2 | İleri |
| 09 Haziran 1994 | 3-for-2 | İleri |
| 23 Mart 1993 | 3-for-2 | İleri |
| 17 Temmuz 1991 | 3-for-2 | İleri |
| 01 Haziran 1988 | 3-for-2 | İleri |
| 03 Eylül 1985 | 3-for-2 | İleri |
| 01 Kasım 1982 | 2-for-1 | İleri |
Accendra Health, Inc. Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Accendra Health is a global healthcare company. It employs over 20,000 people in 70 countries. A Fortune 500 company, it was founded in 1882 in Richmond, Virginia, where it remains headquartered. The company has distribution, production, customer service and sales facilities located across the Asia Pacific region, Europe, Latin America, and North America. President and CEO Ed Pesicka joined Owens & Minor in March 2019.
History
Owens & Minor originally opened as a pharmacy company in downtown Richmond, Virginia in 1882, inside a historic building which still stands today. The company continued this business for over half a century until, in 1954, Gil Minor, Jr. bought out Bodeker Drug Company, a smaller operation in the same industry, changing the company name to Owens, Minor & Bodeker.
In 1966, the company acquired Virginia A&J Hospital Supply, adding medical and surgical distribution to its portfolio. By 1970, OMB had opened Cardinal Drug Centers, merchandising its products to independent drug companies, stocking shops with over 25,000 items within two years. Around this time, disposable items were distributed to hospitals for various medical procedures. G. Gilmer Minor III, a direct relation to the founder, became CEO in 1984. By 1988, Owens & Minor began trading on the New York Stock Exchange under the ticker OMI. It was around this time that revenues earned the company a Fortune 500 ranking.
By 1999, the company had refocused toward medical supply chain management. Throughout the 2000s, Owens & Minor acquired various medical distributors across the United States, notably the hospital distributor McKesson Medical-Surgical Inc., a business unit of McKesson, for $152.1 million, on September 30, 2006. In 2012, it entered the European market, opening offices in Spain, France, Germany, Poland, and the Czech Republic after the acquisition of Movianto Group. In 2014, the corporation acquired ArcRoyal, a privately held medical kit company based in Dublin, Ireland.
In 2018, it acquired Halyard Health’s Surgical & Infection Prevention business for $710 million, the largest acquisition in the company’s history. Halyard is a manufacturer of sterilization wrap, facial protection products, exam gloves, protective apparel, surgical drapes and surgical gowns.
In May 2022, Owens & Minor stated that 45 percent of the items it offers are in some way supply-constrained due to the 2021–2022 global supply chain crisis. The following month, the company broke ground in Morgantown, West Virginia for a 350,000 square-foot medical supplies and logistics center, to be completed in late 2023, which will include dedicated acute care medical distribution facilities and clinical supply capabilities.
In July 2024, the company announced it had agreed to acquire medical equipment firm Rotech Healthcare for $1.36 billion. However, the companies terminated the deal in June 2025, citing regulatory hurtles. As a result, the Owens & Minor paid Rotech an $80 million termination payment.
Personnel
On March 7, 2019 Edward A. Pesicka became president and CEO, then also joined the company's Board of Directors. Pesicka was a former executive at Thermo Fisher Scientific.
Richmond, Virginia center
In the fourth quarter of 2017, Owens & Minor opened a second office and customer service center in downtown Richmond, Virginia as part of a business rebranding strategy. The corporation also continued to work from its various offices across the United States.
Movianto
In 2018, the company’s Movianto subsidiary won a contract estimated at £10.5m a year to warehouse and distribute the UK government’s stock of emergency personal protection equipment (PPE) which had previously been managed by DHL.
Following a dispute over payment of rent, Movianto gained a UK High Court injunction in March 2019 to stop Industrial North West LLP, owner of the rented industrial property, from locking the gates and thereby preventing the company from conducting its business.
In 2020, Movianto was criticised as causing delays to the distribution of the UK government’s stockpile of PPE. Following news of shortages in hospitals, the British army was sent to Movianto’s warehouse to assist in the rapid deployment of PPE, with the Department of Health and Social Care contradicting the allegation. An investigation did establish, however, that Movianto had previously stored the equipment in a smoke-damaged warehouse that was found to contain asbestos.
On January 16, 2020, Owens & Minor announced its intention to sell its European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company providing healthcare logistics services to European markets, with the sale completed June 18, 2020.
Divest of P&HS - Rebrand Accendra Health, Inc.
On December 31 2025, Owens & Minor, Inc. announced the completion of the sale of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand to Platinum Equity and is renaming the publicly traded parent company Accendra Health, Inc.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
| Ex-tarihi | Miktar | Para Birimi | Temettü Verimi |
|---|---|---|---|
| Ara 14, 2021 | $0,00 | USD | ≈0.03% |
| Eyl 14, 2021 | $0,00 | USD | ≈0.03% |
| Haz 14, 2021 | $0,00 | USD | ≈0.03% |
| Mar 12, 2021 | $0,00 | USD | ≈0.03% |
| Ara 14, 2020 | $0,00 | USD | ≈0.04% |
| Eyl 14, 2020 | $0,00 | USD | ≈0.08% |
| Haz 12, 2020 | $0,00 | USD | ≈0.16% |
| Mar 13, 2020 | $0,00 | USD | ≈0.28% |
| Ara 13, 2019 | $0,00 | USD | ≈1.6% |
| Eyl 13, 2019 | $0,00 | USD | ≈5.5% |
| Haz 13, 2019 | $0,00 | USD | ≈20.8% |
| Mar 14, 2019 | $0,00 | USD | ≈12.6% |
| Ara 14, 2018 | $0,08 | USD | ≈13.2% |
| Eyl 14, 2018 | $0,26 | USD | ≈6.4% |
| Haz 14, 2018 | $0,26 | USD | ≈6.4% |
| Mar 14, 2018 | $0,26 | USD | ≈6.2% |
| Ara 14, 2017 | $0,26 | USD | ≈5.5% |
| Eyl 14, 2017 | $0,26 | USD | ≈3.6% |
| Haz 13, 2017 | $0,26 | USD | ≈3.2% |
| Mar 13, 2017 | $0,26 | USD | ≈2.9% |
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 10, 2026 | $-0.19 | $-0.09 | -113.0% |
| 31 Mart 2026 | $-0.04 | $-0.10 | 60.9% | |
| 31 Aralık 2025 | $0.21 | $0.22 | -5.8% | |
| 30 Eylül 2025 | $0.25 | $0.23 | 6.7% | |
| 30 Haziran 2025 | $0.26 | $0.28 | -6.3% | |
| 31 Mart 2025 | $0.23 | $0.20 | 16.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B | $181.02B | $144.85B | |
| Cost of Revenue | $259.70B | $264.17B | $188.52B | $179.28B | $167.11B | $166.29B | $133.70B | |
| Gross Profit | $31.28B | $34.72B | $15.47B | $10.93B | $13.24B | $14.73B | $11.15B | |
| R&D Expense | $4.81B | $2.42B | $1.47B | $941M | $627M | $498M | $169M | |
| SG&A Expense | $6.01B | $6.33B | $5.06B | $3.97B | $3.98B | $4.55B | · | |
| Operating Income | $16.39B | $18.67B | $7.60B | $6.21B | $6.82B | · | · | |
| Interest Expense | $3.83B | $4.51B | $4.99B | $4.38B | $4.69B | $4.83B | $4.76B | |
| Interest Income | $477M | $311M | $266M | $261M | $492M | $707M | $816M | |
| Pretax Income | $13.21B | $14.19B | $2.89B | $1.87B | $2.27B | $3.05B | $1.62B | |
| Income Tax | $2.37B | $2.87B | $641M | $632M | $826M | $644M | $404M | |
| Net Income | $4.19B | $5.76B | $862M | $596M | $709M | $1.41B | $366M | |
| EPS (Basic) | $0.24 | $0.33 | $0.03 | $0.02 | $0.03 | $0.09 | $0.02 | |
| EPS (Diluted) | $0.24 | $0.33 | $0.03 | $0.02 | · | · | · | |
| Shares (Basic) | 17,022,673 | 17,022,673 | 17,022,673 | 17,022,673 | 16,842,714 | 14,903,798,236 | 14,903,798,236 | |
| Shares (Diluted) | · | · | · | 17,022,672,951 | 16,842,713,738 | 14,903,798,236 | 14,903,798,236 | |
| EBITDA | $16.39B | $13.41B | $6.02B | · | · | · | · |
Bilanço
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $16.82B | $19.68B | $9.67B | $7.78B | $19.13B | $27.85B | $23.85B | |
| Receivables | $5.87B | $7.11B | $9.31B | $7.42B | $8.10B | · | · | |
| Inventory | $24.71B | $21.64B | $19.86B | $19.52B | $20.46B | $20.55B | $17.93B | |
| Current Assets | $54.54B | $54.11B | $46.27B | $48.70B | $58.90B | $68.64B | $66.49B | |
| PP&E (Net) | $109.28B | $121.38B | $130.93B | $103.49B | $99.61B | $95.73B | $90.37B | |
| Goodwill | $3.50B | $3.51B | $3.51B | · | · | · | · | |
| Total Assets | $212.35B | $224.86B | $195.04B | $203.14B | $200.96B | $199.82B | $190.51B | |
| Current Liabilities | $62.37B | $61.92B | $62.63B | $69.20B | $74.84B | $90.34B | $83.18B | |
| Total Liabilities | $124.59B | $135.17B | $123.74B | $132.38B | $133.30B | $134.07B | $134.72B | |
| Retained Earnings | $10.09B | $6.81B | $-1.98B | $-2.21B | $-2.86B | $-3.33B | $-4.64B | |
| Stockholders' Equity | $54.40B | $60.48B | $54.45B | $54.67B | $52.42B | $39.69B | $38.17B |
Nakit Akışı
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $8.06B | $7.06B | $7.00B | |
| Operating Cash Flow | $27.75B | $35.16B | $19.42B | $12.51B | $13.02B | $13.21B | $11.61B | |
| CapEx | $4.42B | $3.19B | $10.33B | $9.05B | $6.75B | $8.89B | $6.33B | |
| Investing Cash Flow | $-3.42B | $-1.67B | $-3.31B | $-13.40B | $-5.53B | $-5.60B | $-2.63B | |
| Dividends Paid | $2.51B | $579M | $423M | $223M | $328M | $309M | $20M | |
| Financing Cash Flow | $-27.04B | $-23.41B | $-18.23B | $-10.47B | $-16.28B | $-3.39B | $-6.11B | |
| Free Cash Flow | $23.33B | $26.19B | $9.84B | $3.58B | · | · | · | |
| Levered FCF | $20.19B | $23.50B | $7.02B | $501M | · | · | · |
Kârlılık
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 10.8% | 9.8% | 7.2% | 6.4% | · | · | · | |
| Operating Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| Net Margin | 1.4% | 1.9% | 0.40% | 0.45% | · | · | · | |
| Pretax Margin | 4.5% | 3.8% | 1.2% | 1.1% | · | · | · | |
| EBITDA Margin | 5.6% | 5.0% | 3.2% | · | · | · | · | |
| ROA | 1.9% | 2.6% | 0.37% | 0.42% | · | · | · | |
| ROE | 7.3% | 9.1% | 1.4% | 1.6% | · | · | · | |
| ROIC | 24.7% | 17.9% | 8.1% | · | · | · | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 0.9 | 0.7 | 0.7 | · | · | · | |
| Quick Ratio | 0.4 | 0.5 | 0.3 | 0.2 | · | · | · | |
| Interest Coverage | 4.3 | 3.8 | 1.6 | · | · | · | · |
Verimlilik
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.3 | 1.4 | 0.9 | 0.9 | · | · | · | |
| Inventory Turnover | 11.2 | 12.6 | 8.8 | 8.9 | · | · | · | |
| Receivables Turnover | 44.8 | 33.3 | 22.3 | 24.5 | · | · | · |
Hisse Başına
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | · | · | $11.17 | · | · | · | |
| Cash Flow / Share | · | · | · | $0.73 | · | · | · | |
| EPS (TTM) | $0.24 | $0.29 | $0.03 | $0.02 | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $290.99B | $269.75B | $185.99B | $190.22B | · | · | · | |
| Net Income TTM | $4.19B | $5.08B | $764M | $596M | · | · | · | |
| P/E | 81.7 | 152.1 | 901.7 | 235.0 | · | · | · | |
| Earnings Yield | 1.2% | 0.66% | 0.11% | 0.43% | · | · | · | |
| Payout Ratio | 60.0% | 9.1% | 48.1% | 26.2% | · | · | · | |
| Annual Payout | $2.51B | $461M | $356M | $223M | · | · | · |
Hisse Başına
| Metrik | Eğilim | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS (TTM) | · | $0.29 | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | Q4 2022 | Q4 2021 | Q4 2019 | Q4 2018 | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $269.75B | · | · | $144.85B | $123.67B | · | · | · | · | · | |
| Net Income TTM | · | $5.08B | · | · | $366M | $130M | · | · | · | · | · | |
| P/E | · | 152.1 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | 0.66% | · | · | · | · | · | · | · | · | · | |
| Annual Payout | · | $461M | · | · | $20M | $20M | · | · | · | · | · |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Gelir | $290.99B | $298.89B | $203.99B | $190.22B | $180.35B |
| Brüt Kâr Marjı % | 10.8% | 9.8% | 7.2% | 6.4% | · |
| Faaliyet Kâr Marjı % | 5.6% | 5.0% | 3.2% | · | · |
| Net Gelir | $4.19B | $5.76B | $862M | $596M | $709M |
| Seyreltilmiş Hisse Başı Kâr | $0.24 | $0.33 | $0.03 | $0.02 | · |
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 0.9 | 0.9 | 0.7 | 0.7 | · |
| Cari Oran | 0.4 | 0.5 | 0.3 | 0.2 | · |
| Metrik | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $23.33B | $26.19B | $9.84B | $3.58B | · |
Kurumsal Sahipler (13F) 161 dosya · $236.6M toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 22 (-7 önceki Ç'ye göre) | 21 (-25 önceki Ç'ye göre) | 47 (+8 önceki Ç'ye göre) | 45 (-7 önceki Ç'ye göre) | -61K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Coliseum Capital Management, LLC | $44.804.760 | 13.100.807 | 18,94% | Hisse senetleri |
| BlackRock, Inc. | $18.824.028 | 5.504.102 | 7,96% | Hisse senetleri |
| VANGUARD GROUP INC | $17.691.199 | 6.318.285 | 7,48% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $12.912.296 | 3.775.525 | 5,46% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.560.724 | 3.087.931 | 4,46% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $10.538.412 | 3.081.407 | 4,45% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $9.877.158 | 2.888.058 | 4,17% | Hisse senetleri |
| Invenomic Capital Management LP | $9.618.661 | 2.812.474 | 4,07% | Hisse senetleri |
| MARSHALL WACE, LLP | $8.832.423 | 2.582.579 | 3,73% | Hisse senetleri |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $8.675.511 | 2.536.699 | 3,67% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.945.870 | 2.030.956 | 2,94% | Hisse senetleri |
| Dana Investment Advisors, Inc. | $6.650.556 | 1.944.607 | 2,81% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $6.408.062 | 1.873.127 | 2,71% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $5.609.358 | 1.640.163 | 2,37% | Hisse senetleri |
| STATE STREET CORP | $5.475.974 | 1.601.162 | 2,31% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $4.407.652 | 1.288.787 | 1,86% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $3.650.249 | 1.067.324 | 1,54% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $2.923.176 | 854.730 | 1,24% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $2.457.441 | 718.550 | 1,04% | Hisse senetleri |
| NORTHERN TRUST CORP | $1.989.770 | 581.804 | 0,84% | Hisse senetleri |
| WOLVERINE ASSET MANAGEMENT LLC | $1.942.847 | 568.084 | 0,82% | Hisse senetleri |
| TUDOR INVESTMENT CORP ET AL | $1.939.995 | 567.250 | 0,82% | Hisse senetleri |
| JANE STREET GROUP, LLC | $1.833.462 | 536.100 | 0,77% | Alım opsiyonu |
| Vanguard Global Advisers, LLC | $1.742.463 | 509.492 | 0,74% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $1.665.913 | 487.109 | 0,70% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.575.252 | 460.600 | 0,67% | Alım opsiyonu |
| TWO SIGMA ADVISERS, LP | $1.518.922 | 542.472 | 0,64% | Hisse senetleri |
| BW Gestao de Investimentos Ltda. | $1.446.971 | 423.091 | 0,61% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.321.919 | 386.526 | 0,56% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.191.528 | 348.400 | 0,50% | Alım opsiyonu |
| Nebula Research & Development LLC | $1.115.105 | 122.539 | 0,47% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $1.109.492 | 324.413 | 0,47% | Hisse senetleri |
| MORGAN STANLEY | $1.052.342 | 307.701 | 0,44% | Hisse senetleri |
| Linden Thomas Advisory Services, LLC | $932.501 | 272.661 | 0,39% | Hisse senetleri |
| Bank of New York Mellon Corp | $917.257 | 268.204 | 0,39% | Hisse senetleri |
| Nuveen, LLC | $803.515 | 234.946 | 0,34% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $794.692 | 232.366 | 0,34% | Hisse senetleri |
| Kennondale Capital Management LLC | $772.544 | 225.890 | 0,33% | Hisse senetleri |
| STRS OHIO | $716.148 | 209.400 | 0,30% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $690.902 | 202.018 | 0,29% | Hisse senetleri |
| Cubist Systematic Strategies, LLC | $593.424 | 123.630 | 0,25% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $546.095 | 159.677 | 0,23% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $542.754 | 158.700 | 0,23% | Hisse senetleri |
| XTX Topco Ltd | $503.725 | 147.288 | 0,21% | Hisse senetleri |
| ARISTEIA CAPITAL, L.L.C. | $447.391 | 130.816 | 0,19% | Hisse senetleri |
| Invesco Ltd. | $446.351 | 130.512 | 0,19% | Hisse senetleri |
| Man Group plc | $436.009 | 127.488 | 0,18% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $408.047 | 119.312 | 0,17% | Hisse senetleri |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $362.520 | 106.000 | 0,15% | Hisse senetleri |
| Allspring Global Investments Holdings, LLC | $356.879 | 99.687 | 0,15% | Hisse senetleri |
ETF sahipliği 18 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| VFVA · VANGUARD WELLINGTON FUND | 0,17% | 426.785 SH | 19 Ağustos 2026 | Günlük |
| QIDX · Spinnaker ETF Series | 0,11% | 14.310 NS | 31 Temmuz 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 62.833 SH | 19 Ağustos 2026 | Günlük |
| IWC · iShares Trust | 0,02% | 248.081 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 414.904 SH | 19 Ağustos 2026 | Günlük |
| DFSV · Dimensional ETF Trust | 0,01% | 233.042 NS | 31 Temmuz 2026 | N-PORT |
| RSSL · Global X Funds | 0,01% | 34.414 NS | 31 Temmuz 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,00% | 134.690 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 1.902.936 SH | 11 Eylül 2026 | Günlük |
| PRF · Invesco Exchange-Traded Fund Trust | 0,00% | 96.796 SH | 01 Ekim 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,00% | 29.296 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 105.616 SH | 08 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 19.827 SH | 03 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 833.270 SH | 19 Ağustos 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.185.973 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.453 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,00% | 184.892 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 666.394 SH | 11 Eylül 2026 | Günlük |
ACH Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
12 Aylık Fiyat Hedefi
4 analist · 2026-09-30Ortalama hedef $1.51 +199,4%
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.